Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 984 entries
View as:

A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03808493 Org: User:
Start: 01/30/19 End: 03/12/19 Due: 03/12/20

Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01007097 Org: User:
Start: 12/31/09 End: 09/30/10 Due: 09/30/11

Efficacy of Tinoridine in Treating Pain and Inflammation in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01224756 Org: User:
Start: 11/30/10 End: 10/31/11 Due: 10/31/12

Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure

Phase: N/A Priority: Normal
NCT ID: NCT00633477 Org: User:
Start: 02/29/08 End: 02/28/09 Due: 02/28/10

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Phase: N/A Priority: Normal
NCT ID: NCT03341637 Org: User:
Start: 12/14/17 End: 01/26/19 Due: 01/26/20

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT03814005 Org: User:
Start: 07/10/19 End: 04/19/22 Due: 04/19/23

A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03943446 Org: User:
Start: 08/04/20 End: 08/25/22 Due: 08/25/23

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Phase: N/A Priority: Normal
NCT ID: NCT02394795 Org: User:
Start: 05/29/15 End: 01/14/22 Due: 01/14/23

MLN3126 Single Rising Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT02447458 Org: User:
Start: 09/30/13 End: 02/28/14 Due: 02/28/15

A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02372097 Org: User:
Start: 03/31/15 End: 04/30/15 Due: 04/30/16

Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02096458 Org: User:
Start: 02/28/14 End: 02/28/14 Due: 02/28/15

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Phase: N/A Priority: Normal
NCT ID: NCT05677971 Org: User:
Start: 03/06/23 End: 03/31/29 Due: 03/31/30

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01318122 Org: User:
Start: 05/31/08 End: 08/31/09 Due: 08/31/10

Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones

Phase: N/A Priority: Normal
NCT ID: NCT01077284 Org: User:
Start: 02/28/10 End: 11/30/11 Due: 11/30/12

Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies

Phase: N/A Priority: Normal
NCT ID: NCT03166215 Org: User:
Start: 08/17/17 End: 09/19/18 Due: 09/19/19

Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty

Phase: N/A Priority: Normal
NCT ID: NCT02058992 Org: User:
Start: 07/31/10 End: 04/30/13 Due: 04/30/14

A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03608501 Org: User:
Start: 09/30/19 End: 05/31/23 Due: 05/31/24

Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02555618 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge

Phase: N/A Priority: Normal
NCT ID: NCT03409796 Org: User:
Start: 04/24/18 End: 05/02/19 Due: 05/02/20

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

Phase: N/A Priority: Normal
NCT ID: NCT00770653 Org: User:
Start: 04/30/07 End: 05/31/09 Due: 05/31/10

A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone

Phase: N/A Priority: Normal
NCT ID: NCT03433001 Org: User:
Start: 04/02/18 End: 06/11/21 Due: 06/11/22

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02477020 Org: User:
Start: 07/01/15 End: 07/27/16 Due: 07/27/17

A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT05155488 Org: User:
Start: 12/06/21 End: 02/15/22 Due: 02/15/23

Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010

Phase: N/A Priority: Normal
NCT ID: NCT00175019 Org: User:
Start: 07/31/03 End: 02/28/07 Due: 02/28/08

A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03042299 Org: User:
Start: 02/10/17 End: 03/11/17 Due: 03/11/18